Company

Mitochon Pharmaceuticals, Inc.

Blue Bell-based pharmaceutical company developing therapeutics that target mitochondrial dysfunction in neurodegenerative diseases.

About

Mitochon Pharmaceuticals, Inc., founded in 2014 and based in Blue Bell, US, develops therapies for mitochondrial dysfunction in neurodegenerative and neuromuscular diseases, including ALS, Huntington's Disease and Alzheimer's Disease. Co-founded by John Geisler and Robert Alonso, it has raised a total of USD 1.60 mn, with its latest round led by Ben Franklin Technology Partners on June 23, 2020. The description also cites June 2020 funding from the National Institutes of Health.

3Funding rounds

2Investors

Sign in to see more

Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.

Sign in